ARCHIVES

FDA Vs. NCI: Nothing Has Changed; Chabner “Frustrated” By Flutamide Delay

This article is from The Cancer Letter archive.

Vol. 14 No. 41 | October 21, 1988

Download PDF Visit The Full Archive

Related Articles

NCI’s Rosenberg Confirms 2002 Immunotherapy Results

April 29, 2005

CCOPs ask NCI officials about one-year extensions.

May 20, 2005

NCI Charging Use Fee for Compounds In Repository

August 12, 1983

Phase III BETH Study Combining Avastin And Herceptin Open For Enrollment

June 27, 2008

“Sloppy” Searle Studies Described By FDA At Kennedy Hearing; Rauscher “Outraged”

January 23, 1976

Cancer Act Renewal Nears Vote By House

August 11, 1978